For decades, the U.S. has made historic strides in fighting HIV/AIDS, transforming what was once a near-certain death sentence into a manageable chronic condition.
But health experts and advocates warn that recent proposals to slash Medicaid and Centers for Disease Control and Prevention (CDC) funding could unravel years of progress—potentially reversing gains in treatment, prevention, and survival rates.
During the height of the epidemic in the 1980s and early 1990s, physicians like Dr. Abraham Verghese of Stanford University saw patients die within weeks of diagnosis. Advances in medication, federal support, and grassroots activism changed that trajectory, lowering mortality rates and enabling people with HIV to live longer, healthier lives.
Now, that progress is under threat. The “big, beautiful bill” proposed by former President Donald Trump seeks to cut $1 trillion from Medicaid over the next decade. Simultaneously, the administration’s 2026 budget request calls for more than $1.5 billion in CDC funding reductions, including the transfer of $220 million from the Ending the HIV Epidemic initiative to other priorities.
“These moves represent a tragic, short-sighted reversal of one of the most effective public health efforts in modern history,” said Dr. Perry N. Halkitis, dean of the Rutgers School of Public Health.
Medicaid: A Lifeline for HIV Patients
Medicaid is the largest insurer for adults with HIV, covering millions of low-income Americans. At the height of the epidemic, it funded more than half of AIDS-related care and up to 90% of pediatric treatment. Today, the high cost of HIV medications—often up to $46,000 annually—makes coverage essential for many patients.
Clinics like Washington, D.C.’s Whitman-Walker Health say nearly half their patients rely on Medicaid as primary insurance, not just for medication, but for mental health, dental, and preventive care. The Ryan White HIV/AIDS Program and the AIDS Drug Assistance Program also play critical roles in filling coverage gaps.
The CDC and National Institutes of Health (NIH) have invested decades into HIV research, from identifying the virus to developing prevention strategies like the Ready, Set, PrEP campaign. Federal surveillance systems have been vital in tracking new cases and linking patients to care.
Cuts Threaten to Reverse Decades of Progress
The proposed Medicaid changes would impose stricter eligibility requirements, expand work mandates, and shift costs to states—potentially leaving 16 million Americans uninsured by 2034. HIV/AIDS patients, particularly in marginalized communities, would be disproportionately affected.
CDC funding cuts would shrink national testing, education, and prevention programs, and reduce resources for local health departments. They follow earlier moves by the administration to eliminate five HIV prevention branches at the CDC and cancel NIH grants related to LGBTQ+ and HIV research—though some cancellations are currently blocked in court.
Without robust funding, experts fear a return to conditions seen in the early 1990s, when AIDS deaths peaked at over 40,000 annually. “We were on track to end AIDS as a public health threat under the UNAIDS 95-95-95 plan,” said Halkitis. “These cuts dismantle that vision.”
Local and National Impact
Advocates in states like Texas, home to over 100,000 people living with HIV, warn that Medicaid cuts could mean more diagnoses, hospitalizations, and deaths. In Washington, D.C., officials say the potential loss of coverage is already causing panic among patients, forcing some to choose between medication, housing, and food.
Dr. Verghese cautions that CDC cuts will weaken infection control, while reduced NIH funding could stall future breakthroughs. “When the next health threat emerges, we may not have the research foundation we need to respond,” he said.
For many living with HIV, Medicaid is more than insurance—it’s a lifeline. Without it, experts warn, decades of hard-won progress could vanish almost overnight.
READ MORE
CDC Director Warns of Misinformation in First Meeting After Shooting
IBS Symptoms Continue to Significantly Affect Patients’ Daily Lives
Online Vendors Mislead with False Health Claims on Ordinary Foods
